IPHA
Innate Pharma
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
IPHA Profile
Innate Pharma S.A.
A company that developing therapeutic antibodies designed to harness the immune system to treat cancer
Biological Technology
09/23/1999
10/17/2019
NASDAQ Stock Exchange
181
12-31
Depository Receipts (Ordinary Shares)
117 Avenue de Luminy, 13009 Marseille, France
--
Founded on September 23, 1999, Innate Pharma S.A. is a biotechnology company dedicated to the discovery, development and commercialization of first-in-class therapeutic antibodies designed to harness the immune system for the treatment of tumor indications with serious unmet medical needs. The company has extensive experience in the research and development of immuno-oncology and is a pioneer in understanding natural killer cell or NK cell biology.